Latest News
Wales is developing a diabetes mental health pathway to give people faster access to specialist support, in what experts say is a UK first. The model aims to provide more joined-up support for people whose mental health and diabetes management are closely tied together. It follows growing concern that people with diabetes are often passed [...]
Agetech investment round-up featuring Life Biosciences, Eli Lilly, L-Nutra & LinkGevity The first quarter of 2026 has been a record one in healthy-ageing finance with some US$3.74bn of investment across 49 deals - an increase of 56% in total financing against the same period last year And, the second quarter has gotten off to a [...]
Leading healthy-ageing scientist Dr David Sinclair is using AI to build a pill that reverses ageing with a targeted price of US$100. Explaining the science behind these developments Dr Sinclair says all human cells carry the same DNA, with the determination of their exact role being a function of the cell overlord - the epigenome [...]
Alzheimer’s drug pioneer Anavex is pressing ahead with plans to secure approval for its ground-breaking treatment despite a recent setback. Earlier this year it lodged an appeal against the European Medicines Agency (EMA) decision to reject its application for drug approval in December 2025. But, Anavex has now withdrawn this appeal as it seeks to [...]
In the latest piece from our special 'Live Forever' series we hear from Dr Clint Phillips, CEO and founder of Medici. Biohacking is a fun, trendy word however if you look at the root of its meaning, it’s not necessarily a term that I encourage people to idolize. Hacking usually implies finding a secret back [...]
So-called 'gamechanger' Alzheimer’s drugs made little noticeable difference for patients in trials, according to a review of anti-amyloid drugs. The analysis looked at trials involving people with mild cognitive impairment or mild dementia. It found the effects of anti-amyloid drugs on cognition and dementia severity over 18 months were “trivial”, while gains in functional ability [...]
A pancreatic cancer drug could double survival rates and cut the risk of death by more than a third, a trial suggests. Pancreatic cancer survival rates are among the lowest of all cancers, with only about 10 per cent of patients in Britain living longer than a year after diagnosis. Researchers at Northwestern University in [...]
Loneliness may harm memory at first, but a major European study tracking more than 10,000 people over seven years suggests it does not speed dementia decline over time. Study participants who reported high levels of loneliness performed worse on memory tests at the start of the research period. However, their ability to recall information declined at [...]
Liver disease linked to obesity and high blood sugar could affect 1.8bn people worldwide by 2050, a study suggests. Metabolic dysfunction-associated steatotic liver disease, or MASLD, was previously known as non-alcoholic fatty liver disease. It is one of the most common and fastest-growing liver conditions worldwide. There are now 1.3bn people worldwide living with MASLD, [...]
A Picasso raffle offering a €1m portrait with €100 tickets is set to raise money for Alzheimer’s research. Picasso painted the gouache-on-paper Tête de Femme (Head of a Woman) in 1941. The raffle organisers’ online sales platform says the number of tickets will be capped at 120,000, meaning the draw could net €12m if they [...]
